This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XELJANZ XR 11 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $16,332.64, has a completion date of May 3, 2024 and is a firm fixed price delivery order contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract does not have a set-aside designation.
Generated 8/1/24, 9:29 AM